4//SEC Filing
Ciulla Thomas 4
Accession 0001209191-23-002341
CIK 0001539029other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:27 PM ET
Size
8.9 KB
Accession
0001209191-23-002341
Insider Transaction Report
Form 4
Ciulla Thomas
Chief Medical Officer
Transactions
- Award
Common Stock
2022-06-30$1.25/sh+5,000$6,250→ 302,760 total - Award
Employee Stock Option (right to buy)
2023-01-04+187,500→ 187,500 totalExercise: $1.48Exp: 2033-01-04→ Common Stock (187,500 underlying) - Award
Common Stock
2022-12-31$0.95/sh+5,000$4,750→ 307,760 total
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]One-fourth of the shares underlying this option vest on January 4, 2024 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001815426
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:27 PM ET
- Size
- 8.9 KB